capsensixx AG

As of December 31, 2022, capsensixx AG has 3.09M shares outstanding.

As of December 31, 2022, capsensixx AG maintains a current ratio of 2.52, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 21.38, indicating elevated leverage, while an interest coverage ratio of 101.76 demonstrates strong ability to service its debt obligations.

Over the twelve months ended December 31, 2022, capsensixx AG posted a return on equity (ROE) of 21.21, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 21.09 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 3.94, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is negative at -1.32, pointing to unprofitable operations over the period.

These figures cover the twelve months ended December 31, 2022. That works out to an effective tax rate of 29.04, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.

Over the twelve months ended December 31, 2022, capsensixx AG posted a gross margin of 15.02, reflecting its pricing power and cost economics. The operating margin of 7.31 and net profit margin of 2.38 provide insight into operational efficiency.

As of December 31, 2022, capsensixx AG has an Altman Z-Score of 4.48, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.